Corpus Intelligence IC Memo — TRINITY HEALTH ANN ARBOR 2026-04-26 11:18 UTC
IC Memo — TRINITY HEALTH ANN ARBOR
Investment Committee Memorandum | MI | 475 beds | Grade B | EBITDA uplift $73.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

TRINITY HEALTH ANN ARBOR

CCN 230156 | nan, MI | 475 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

TRINITY HEALTH ANN ARBOR is a 475-bed suburban community hospital in nan, MI with $1.00B in net patient revenue and a -1.0% operating margin. The hospital serves a payer mix of 23.7% Medicare, 3.9% Medicaid, and 72.4% commercial.

Thesis: Undervalued. Our ML models identify $73.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -1.0% to 6.4% (+736bps).

Net Revenue HCRIS$1.00B
Current EBITDA COMPUTED$-10.0M
Operating Margin COMPUTED-1.0%
Occupancy HCRIS85.3%
Revenue / Bed COMPUTED$2.1M
Net-to-Gross HCRIS30.2%
Distress Probability ML39.8%

2. Market Context & Competitive Position

163
MI Hospitals
-5.2%
State Median Margin
25
Comparable Hospitals

MI has 163 Medicare-certified hospitals with a median operating margin of -5.2%. The target's margin of -1.0% places it above the state median. Among 25 size-comparable peers (238-950 beds), the median margin is -7.2%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (238-950), prioritizing same-state peers. 25 hospitals in the comp set.

HospitalStateBedsRevenueMargin
TRINITY HEALTH ANN ARBOR (Target)MI475$1.00B-1.0%
HENRY FORD HOSPITALMI670$2.32B-14.8%
BRONSON METHODIST HOSPITALMI439$1.06B-1.4%
EDWARD W. SPARROW HOSPITALMI425$936.1M-24.5%
ASCENSION ST JOHN HOSPITALMI556$929.1M-9.6%
ASCENSION PROVIDENCE HOSPITALMI527$849.3M-6.5%
WILLIAM BEAUMONT HOSPITAL - TRMI484$747.4M2.3%
MUNSON MEDICAL CENTERMI401$710.9M-7.0%
W.A. FOOTE MEMORIAL HOSPITALMI331$681.8M-9.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $73.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$21.0M+210bp18mo
Cost to Collect4.5%2.5%$20.0M+200bp12mo
Denial Rate Reduction12.0%6.5%$19.8M+198bp12mo
A/R Days Reduction5200.0%3800.0%$12.2M+122bp9mo
Clean Claim Rate88.0%96.0%$640K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$21.0M
Cost to Collect
$20.0M
Denial Rate Reduction
$19.8M
A/R Days Reduction
$12.2M
Clean Claim Rate
$640K
Total EBITDA Uplift$73.6M
Current EBITDA$-10.0M
+ RCM Uplift+$73.6M
Pro Forma EBITDA$63.7M
Current Margin-1.0%
Pro Forma Margin6.4%
WC Released (1x)$38.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-15.3M$670.6M0.00x-100.0%
Base (11x exit)10.0x11.0x$-15.3M$732.7M0.00x-100.0%
Bull Case9.0x11.0x$-13.8M$970.8M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-13.8M$1.05B0.00x-100.0%
Bear Case11.0x10.0x$-16.9M$307.4M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-16.9M$332.7M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 25 hospitals with 238-950 beds
  • Same-state prioritization (n=26)
  • Comp margins: P25=-10.5% / P50=-7.2% / P75=-3.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.